COVID-19: Implications for People with Chagas Disease
As the global COVID-19 pandemic advances, it increasingly impacts those vulnerable populations who already bear a heavy burden of neglected tropical disease. Chagas disease (CD), a neglected parasitic infection, is of particular concern because of its potential to cause cardiac, gastrointestinal, an...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2020-10-01
|
Series: | Global Heart |
Subjects: | |
Online Access: | https://globalheartjournal.com/articles/891 |
id |
doaj-731ad5ca9dd54ac397ccf0d31addbb1f |
---|---|
record_format |
Article |
spelling |
doaj-731ad5ca9dd54ac397ccf0d31addbb1f2020-11-25T04:07:17ZengUbiquity PressGlobal Heart2211-81792020-10-0115110.5334/gh.891800COVID-19: Implications for People with Chagas DiseaseEzequiel José Zaidel0Colin J. Forsyth1Gabriel Novick2Rachel Marcus3Antonio Luiz P. Ribeiro4María-Jesus Pinazo5Carlos A. Morillo6Luis Eduardo Echeverría7Maria Aparecida Shikanai-Yasuda8Pierre Buekens9Pablo Perel10Sheba K. Meymandi11Kate Ralston12Fausto Pinto13Sergio Sosa-Estani14Sanatorio Güemes, Buenos Aires; Pharmacology Department, School of Medicine, University of Buenos AiresDrugs for Neglected Diseases initiative-Latin America, Rio de JaneiroSwiss Medical Group, Buenos Aires, AR; Friedman School of Nutrition Science and Policy, Tufts University, BostonLatin American Society of Chagas, Washington, DCInternal Medicine Department, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte; Hospital das Clínicas, UFMG, Belo HorizonteISGlobal, Hospital Clínic – University of Barcelona, BarcelonaLibin Cardiovascular Institute, University of Calgary, CalgaryDepartment of Cardiology, Cardiovascular Foundation of Colombia, FloriblancaDepartment of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, São PauloTulane University School of Public Health and Tropical Medicine, New OrleansWorld Heart Federation, Geneva, CH; Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, LondonCenter of Excellence for Chagas Disease at Olive View-UCLA Medical Center, SylmarWorld Heart Federation, GenevaWorld Heart Federation, Geneva, CH; Department of Cardiology, CCUL, Lisbon School of Medicine, Universidade de LisboaDrugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, BR; Epidemiology and Public Health Research Center, (CIESP-CONICET), Buenos AiresAs the global COVID-19 pandemic advances, it increasingly impacts those vulnerable populations who already bear a heavy burden of neglected tropical disease. Chagas disease (CD), a neglected parasitic infection, is of particular concern because of its potential to cause cardiac, gastrointestinal, and other complications which could increase susceptibility to COVID-19. The over one million people worldwide with chronic Chagas cardiomyopathy require special consideration because of COVID-19’s potential impact on the heart, yet the pandemic also affects treatment provision to people with acute or chronic indeterminate CD. In this document, a follow-up to the WHF-IASC Roadmap on CD, we assess the implications of coinfection with SARS-CoV-2 and 'Trypanosoma cruzi', the etiological agent of CD. Based on the limited evidence available, we provide preliminary guidance for testing, treatment, and management of patients affected by both diseases, while highlighting emerging healthcare access challenges and future research needs.https://globalheartjournal.com/articles/891covid-19chagas diseaseneglected tropical disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ezequiel José Zaidel Colin J. Forsyth Gabriel Novick Rachel Marcus Antonio Luiz P. Ribeiro María-Jesus Pinazo Carlos A. Morillo Luis Eduardo Echeverría Maria Aparecida Shikanai-Yasuda Pierre Buekens Pablo Perel Sheba K. Meymandi Kate Ralston Fausto Pinto Sergio Sosa-Estani |
spellingShingle |
Ezequiel José Zaidel Colin J. Forsyth Gabriel Novick Rachel Marcus Antonio Luiz P. Ribeiro María-Jesus Pinazo Carlos A. Morillo Luis Eduardo Echeverría Maria Aparecida Shikanai-Yasuda Pierre Buekens Pablo Perel Sheba K. Meymandi Kate Ralston Fausto Pinto Sergio Sosa-Estani COVID-19: Implications for People with Chagas Disease Global Heart covid-19 chagas disease neglected tropical disease |
author_facet |
Ezequiel José Zaidel Colin J. Forsyth Gabriel Novick Rachel Marcus Antonio Luiz P. Ribeiro María-Jesus Pinazo Carlos A. Morillo Luis Eduardo Echeverría Maria Aparecida Shikanai-Yasuda Pierre Buekens Pablo Perel Sheba K. Meymandi Kate Ralston Fausto Pinto Sergio Sosa-Estani |
author_sort |
Ezequiel José Zaidel |
title |
COVID-19: Implications for People with Chagas Disease |
title_short |
COVID-19: Implications for People with Chagas Disease |
title_full |
COVID-19: Implications for People with Chagas Disease |
title_fullStr |
COVID-19: Implications for People with Chagas Disease |
title_full_unstemmed |
COVID-19: Implications for People with Chagas Disease |
title_sort |
covid-19: implications for people with chagas disease |
publisher |
Ubiquity Press |
series |
Global Heart |
issn |
2211-8179 |
publishDate |
2020-10-01 |
description |
As the global COVID-19 pandemic advances, it increasingly impacts those vulnerable populations who already bear a heavy burden of neglected tropical disease. Chagas disease (CD), a neglected parasitic infection, is of particular concern because of its potential to cause cardiac, gastrointestinal, and other complications which could increase susceptibility to COVID-19. The over one million people worldwide with chronic Chagas cardiomyopathy require special consideration because of COVID-19’s potential impact on the heart, yet the pandemic also affects treatment provision to people with acute or chronic indeterminate CD. In this document, a follow-up to the WHF-IASC Roadmap on CD, we assess the implications of coinfection with SARS-CoV-2 and 'Trypanosoma cruzi', the etiological agent of CD. Based on the limited evidence available, we provide preliminary guidance for testing, treatment, and management of patients affected by both diseases, while highlighting emerging healthcare access challenges and future research needs. |
topic |
covid-19 chagas disease neglected tropical disease |
url |
https://globalheartjournal.com/articles/891 |
work_keys_str_mv |
AT ezequieljosezaidel covid19implicationsforpeoplewithchagasdisease AT colinjforsyth covid19implicationsforpeoplewithchagasdisease AT gabrielnovick covid19implicationsforpeoplewithchagasdisease AT rachelmarcus covid19implicationsforpeoplewithchagasdisease AT antonioluizpribeiro covid19implicationsforpeoplewithchagasdisease AT mariajesuspinazo covid19implicationsforpeoplewithchagasdisease AT carlosamorillo covid19implicationsforpeoplewithchagasdisease AT luiseduardoecheverria covid19implicationsforpeoplewithchagasdisease AT mariaaparecidashikanaiyasuda covid19implicationsforpeoplewithchagasdisease AT pierrebuekens covid19implicationsforpeoplewithchagasdisease AT pabloperel covid19implicationsforpeoplewithchagasdisease AT shebakmeymandi covid19implicationsforpeoplewithchagasdisease AT kateralston covid19implicationsforpeoplewithchagasdisease AT faustopinto covid19implicationsforpeoplewithchagasdisease AT sergiososaestani covid19implicationsforpeoplewithchagasdisease |
_version_ |
1724429414496731136 |